So exciting!
Britain authorizes Merck’s covid-19 treatment pill molnupiravir, in the world’s first approval of drug
By Ellen Francis and Claire Parker
Today at 6:32 a.m. EDT
LONDON - Regulators in Britain granted approval to the experimental drug molnupiravir from U.S. pharmaceutical giant Merck on Thursday, marking the first authorization from a public health body for an oral antiviral treatment for covid-19 in adults.
Experts say that if widely authorized, molnupiravir could have huge potential to help fight the pandemic: Pills are easier to take, manufacture and store, making them particularly useful in lower- to middle-income countries with weaker infrastructure and limited vaccine supplies.
“We will continue to move with both rigor and urgency to bring molnupiravir to patients around the world as quickly as possible,” Merck president Robert M. Davis said in a statement announcing the U.K. approval.
The company has applied to the U.S. Food and Drug Agency for emergency use authorization, while the European Medicines Agency has launched a rolling review of the oral antiviral medicine. It said it was also working to submit applications to other regulatory agencies.
more:
http://www.washingtonpost.com/health/2021/11/04/covid19-pill-merck-molnupiravir-approval-uk/
Do something positive.
| 